119 related articles for article (PubMed ID: 9233837)
1. Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival.
Yang EB; Tang WY; Zhang K; Cheng LY; Mack PO
Cancer Lett; 1997 Jul; 117(1):93-8. PubMed ID: 9233837
[TBL] [Abstract][Full Text] [Related]
2. Atg5 siRNA inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma.
Xiong X; Wu M; Zhang H; Li J; Lu B; Guo Y; Zhou T; Guo H; Peng R; Li X; Tian Q; Wang Y
Int J Oncol; 2015 Oct; 47(4):1321-8. PubMed ID: 26240015
[TBL] [Abstract][Full Text] [Related]
3. Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation.
Wang D; Yang C; Wang Z; Yang Y; Li D; Ding X; Xu W; Zheng Q
Sci Rep; 2017 Aug; 7(1):9373. PubMed ID: 28839202
[TBL] [Abstract][Full Text] [Related]
4. In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin.
Xie MH; Ge M; Peng JB; Jiang XR; Wang DS; Ji LQ; Ying Y; Wang Z
Pharm Dev Technol; 2019 Jun; 24(5):623-629. PubMed ID: 30457414
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC
Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869
[TBL] [Abstract][Full Text] [Related]
6. Effect of norcantharidin on N-acetyltransferase activity in HepG2 cells.
Wu LT; Chung JG; Chen JC; Tsauer W
Am J Chin Med; 2001; 29(1):161-72. PubMed ID: 11321474
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma.
Jiang S; Li M; Hu Y; Zhang Z; Lv H
Carbohydr Polym; 2018 Oct; 197():194-203. PubMed ID: 30007605
[TBL] [Abstract][Full Text] [Related]
8. [Norcantharidin induces apoptosis in SMMC-7721 cells via the c-Jun-NH2-terminal kinase signaling pathways].
Li XQ; Shao SH; Han XH; Fan ZZ; Sun J; Yin PH; Gao H; Sun YN
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):146-7. PubMed ID: 20196957
[No Abstract] [Full Text] [Related]
9. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
Ren J; Li G; Zhao W; Lin L; Ye T
World J Gastroenterol; 2016 Apr; 22(15):3962-8. PubMed ID: 27099439
[TBL] [Abstract][Full Text] [Related]
10. [Studies on anti-tumor agents. I: Synthesis and anti-cancer activity of amino acid derivatives of norcantharidin].
Tian SL; Zhao SW; Zhu AT; Fang Y; Li KQ
Yao Xue Xue Bao; 1993; 28(11):870-5. PubMed ID: 8010005
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis and anticancer activity of norcantharidin-galactose derivatives].
Fan F; Sun XF
Yao Xue Xue Bao; 2008 Feb; 43(2):157-61. PubMed ID: 18507342
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of in vivo adriamycin-induced multidrug resistance models of subcutaneous and hepatic transplanted human liver cancer in nude mice].
Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB
Ai Zheng; 2004 Aug; 23(8):905-9. PubMed ID: 15301712
[TBL] [Abstract][Full Text] [Related]
13. Effects of doxorubicin, mitomycin C, and ethanol on Hep-G2 cells in vitro.
Castañeda F; Kinne RK
J Cancer Res Clin Oncol; 1999; 125(1):1-8. PubMed ID: 10037271
[TBL] [Abstract][Full Text] [Related]
14. Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin.
Zhang Z; Yang L; Hou J; Xia X; Wang J; Ning Q; Jiang S
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S630-S640. PubMed ID: 30449176
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effects of iressa on hepatocellular carcinoma Hep-3B and HepG2 cell xenografts in nude mice].
Xu L; Zhang YJ; Lin XJ; Li JQ
Ai Zheng; 2006 Apr; 25(4):447-50. PubMed ID: 16613678
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of intra-arterial norcantharidin in suppressing tumour 14C-labelled glucose oxidative metabolism in rat Morris hepatoma.
Mack P; Ha XF; Cheng LY
HPB Surg; 1996; 10(2):65-72. PubMed ID: 9184858
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B
Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
[TBL] [Abstract][Full Text] [Related]
18. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
19. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
[TBL] [Abstract][Full Text] [Related]
20. IP6 in treatment of liver cancer. II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice.
Vucenik I; Zhang ZS; Shamsuddin AM
Anticancer Res; 1998; 18(6A):4091-6. PubMed ID: 9891450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
